126 related articles for article (PubMed ID: 16855006)
1. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice.
Moffatt JD; Lever R; Page CP
FASEB J; 2006 Sep; 20(11):1877-9. PubMed ID: 16855006
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
[TBL] [Abstract][Full Text] [Related]
5. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
6. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
7. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2.
Abd El-Aziz SM; Abdel-Wahab BA
Can J Physiol Pharmacol; 2011 Nov; 89(11):783-91. PubMed ID: 22007876
[TBL] [Abstract][Full Text] [Related]
8. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
Martínez V; Wang L; Rivier JE; Vale W; Taché Y
J Pharmacol Exp Ther; 2002 May; 301(2):611-7. PubMed ID: 11961064
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CRH receptors in urocortin-induced hyperthermia.
Telegdy G; Adamik A
Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
14. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
Uchida M; Suzuki M; Shimizu K
Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
[TBL] [Abstract][Full Text] [Related]
15. Urocortin-induced relaxation in the human internal mammary artery.
Chen ZW; Huang Y; Yang Q; Li X; Wei W; He GW
Cardiovasc Res; 2005 Mar; 65(4):913-20. PubMed ID: 15721872
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
Larson AA; Nunez MG; Kissel CL; Kovács KJ
Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
Yin Y; Dong L; Yin D
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
[TBL] [Abstract][Full Text] [Related]
18. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
19. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
[TBL] [Abstract][Full Text] [Related]
20. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.
Wang L; Martínez V; Rivier JE; Taché Y
Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1401-10. PubMed ID: 11641109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
